Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Oct 29, 2026
Reporting period
Not applicable
Filed with the SEC
Oct 30, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001104659-26-120652
Filed / recorded
Oct 30, 2026, 8:02 PM UTC
Added to OQRO
Oct 30, 2026, 8:05 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Yarrow Bioscience, Inc.
Issuer CIK
1566044
Ticker
YARW
Reporting person
Steven Ryder
Relationship
Officer
Officer title
Chief Medical Officer
Security
Stock Option (Right to Buy)
Table
Derivative (Table II)
Transaction date
Oct 29, 2026
Transaction code
A
Shares / units
113,137
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
113,137
Ownership form
Direct
Amendment
No
Footnotes from the filing
This option represents a right to purchase 113,137 shares of the Issuer's common stock, one quarter of which will vest on July 28, 2027, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.